MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

BD Launches Glass Prefillable Syringe for Biopharmaceuticals

Article-BD Launches Glass Prefillable Syringe for Biopharmaceuticals

Image courtesy of BD Effivax-2-ftd.jpeg
BD designed the Effivax glass prefillable syringe to run efficiently on fill/finish packaging lines to improve biopharmaceutical manufacturing operations.
Designed for reliability and efficiency, Effivax supports the rapid growth and stringent needs of vaccine manufacturing.

In collaboration with leading pharmaceutical companies, Becton Dickinson has introduced a next-generation glass prefillable syringe (PFS). Effivax’s design enhancements are focused on fill/finish and container reliability to help the company’s biopharmaceutical customers meet the stringent demands of vaccine manufacturing. 

The syringe reduces the risk of line stoppage and improves total cost of ownership, manufacturing capacity, and supply availability.

“As biopharmaceutical companies continue to rapidly grow their vaccine pipelines, demand for PFS is accelerating across the globe — given their proven ability to facilitate faster administration, support dose sparing, and reduce vaccine waste,” says Eric Borin, worldwide president of BD Pharmaceutical Systems. “The launch of BD Effivax glass prefillable syringe strategically supports this growth and will create needed efficiencies in end-to-end production.”

Effivax will benefit from BD’s $1.2 billion, four-year investment announced in 2020 to expand and upgrade its manufacturing capacity and technology for PFS. 

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.